Clinical trial
Neoadjuvant/Adjuvant Trial of Darovasertib in Ocular Melanoma
NCT05187884 is registered in ClinicalTrials.gov with St Vincent's Hospital, Sydney as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neoadjuvant/Adjuvant Trial of Darovasertib in Ocular Melanoma
- Lead sponsor
- St Vincent's Hospital, Sydney
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 3, 2022
- Completion date
- November 1, 2025
- Enrollment
- 15 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
ocular melanoma